Chester County News and Community Website
LANGHORNE, PA — Biopharmaceutical company Savara Inc. (Nasdaq: SVRA) disclosed its financial outcomes for the first quarter ended March 31, 2024, while casting an optimistic glance towards its pipeline’s progress …
Savara Inc. Eyes Future Growth with Ongoing IMPALA-2 Trial and Strategic Investments Read More
NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) recently disclosed its financial outcomes for the first quarter ended March 31, 2024, revealing a slight downturn in revenues but maintaining a …
EPAM Systems Reports First Quarter Results and Adjusts Full-Year Outlook Amid Challenging Demand Read More LAHASKA, PA — Specialty Care Management (SCM) recently announced a strategic alliance with Springbuk, a leading health intelligence platform that serves employers and benefits advisors. This partnership aims to leverage …
Specialty Care Management Partners with Springbuk to Tackle High-Cost Dialysis Claims Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced it will release its first quarter financial results for 2024, along with corporate updates, prior to the market opening on Tuesday, May …
Optinose to Unveil First Quarter 2024 Financial Results and Updates Read More
NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) is set to announce its financial outcomes for the first quarter of 2024 on Monday, May 13, after the market closure.
Helius Medical Technologies to Unveil Q1 2024 Results and Discuss PoNS® U.S. Commercialization Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) is set to reveal its first quarter financial performance for 2024 after the market closes on May 13, 2024.
NEXGEL to Unveil First Quarter Financial Results and Host Conference Call Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) will present at two investor conferences in New York next month.
Arbutus Biopharma to Engage Investors at Upcoming New York Conferences Read More
NEWTOWN, PA — Traws Pharma, Inc. announced this week the completion of dosing in the first cohort of a groundbreaking Phase 1 study on travatrelvir (TRX01), an innovative oral protease …
Traws Pharma Advances COVID-19 Treatment into First Human Trials Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a clinical-stage biopharmaceutical company, has successfully navigated back to compliance with Nasdaq’s minimum bid price requirement, a crucial step for maintaining its …
Windtree Therapeutics Regains Nasdaq Compliance with Minimum Bid Price Requirement Read More
SOUTHAMPTON, PA — Drumming up impressive figures amidst challenging financial landscapes, Quaint Oak Bancorp, Inc., in the first quarter of 2024, reveled in a notable 55.1% surge in their net …
Quaint Oak Bancorp Reports Stellar Growth in Q1 2024 amid Subsidiary Divestments Read More